is semaglutide ototoxic Possible mechanisms of on oxidative stress and Semaglutide - Wikipedia

Market Overview The oral GLP-1 drug market is rapidly evolving from a supplementary dosage form for diabetes treatment into a broader therapeutic market covering type 2 diabetes, obesity and cardiometabolic risk management

Genetics and epigenetics of IBD

Repurposing of long-acting FDA-approved GLP-1 receptor agonists such as semaglutide, the dual GLP-1/gastric inhibitory polypeptide (GIP) receptor agonist tirzepatide, and the triple-agonist retatrutide which additionally targets glucagon receptors and is currently in clinical trials for obesity, may offer a promising strategy treating AUD

They had MRI scans to measure the amount of fat in their liver and were then randomly assigned to receive either tirzepatide (at doses of 5 mg, 10 mg, or 15 mg) or insulin degludec (taken once a day)

The prevalence of gout and hyperuricaemia in Australia: An updated systematic review